Last reviewed · How we verify
NCT02987803
Helping Mothers Select Better Childbirth Hospitals
NA trial testing Data in Cesarean Section in 120,621 participants. Completed in 30 June 2021.
30 June 2021
Quick facts
| Lead sponsor | Harvard School of Public Health (HSPH) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 120,621 |
| Start date | 15 August 2019 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Data
Conditions studied
- Cesarean Section — all drugs for Cesarean Section →
Sponsor
Harvard School of Public Health (HSPH)
Who can join
18 and older, female only, with Cesarean Section. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim to conduct a randomized controlled trial of women who are pregnant or considering pregnancy to understand whether women provided with specific data on hospital-level cesarean delivery rates are more likely to select higher quality hospitals, defined as hospitals with cesarean delivery rates below the Federal HealthyPeople 2020 target of 23.9%.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Does comparing cesarean delivery rates influence women's choice of obstetric hospital?
Gourevitch RA, Mehrotra A, Galvin G, Plough AC, et al · · 2019 · cited 6× · PMID 30763041 -
Impact of an educational program and decision tool on choice of maternity hospital: the delivery decisions randomized clinical trial.
Mehrotra A, Wolfberg A, Shah NT, Plough A, et al · · 2022 · cited 4× · PMID 36217115 · DOI 10.1186/s12884-022-05087-y -
Impact of an Educational Program and Decision Tool on Choice of Maternity Hospital: The Delivery Decisions Randomized Clinical Trial
MEHROTRA A, WOLFBERG A, SHAH N, Plough A, et al · · 2022 · DOI 10.21203/rs.3.rs-1523407/v1
Verify or expand the search:
- PubMed search for NCT02987803
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Data
Trials testing the same drug.
- NCT01677533 — Program for Research on the Outcomes of VA Education · NA · completed
Other recruiting trials for Cesarean Section
Currently open trials in the same condition.
- NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting
- NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
- NCT07440667 — Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section · NA · recruiting
Other Harvard School of Public Health (HSPH) trials
Trials by the same sponsor.
- NCT07493772 — Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania · NA · not yet recruiting
- NCT06982339 — Beat the Heat Boston · NA · recruiting
- NCT06765863 — LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk · NA · recruiting
- NCT06102044 — Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania · Phase 3 · recruiting
- NCT06390943 — Low Birthweight and Preterm Infant Feeding Trial and Supportive Care Package: Implementation Research · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02987803 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Harvard School of Public Health (HSPH)
- Last refreshed: 29 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02987803.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing